Banyu to Close Tsukuba Lab as Part of Merck’s Global Research Revamp
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Merck subsidiary Banyu Pharmaceutical, said Oct. 23 it would close its research laboratory in Tsukuba City, northeast of Tokyo, by the end of 2009, leaving only a fraction of foreign drug makers with basic research activities in Japan
You may also be interested in...
Discovery Research In Japan By Global Pharmas: Evolving More Toward Partnerships? (Part 1 of 3)
While some globe-spanning pharmaceutical companies are maintaining or increasing their investment in discovery research in Japan, many more are moving in the opposite direction.
Discovery Research In Japan By Global Pharmas: Evolving More Toward Partnerships? (Part 1 of 3)
While some globe-spanning pharmaceutical companies are maintaining or increasing their investment in discovery research in Japan, many more are moving in the opposite direction.
Merck To Close Plant In South Korea As Part Of Global Supply Strategy
SHANGHAI - Merck will close down its plant in South Korea, the U.S.-based drug maker said Nov. 3